Loyal
More time with the dogs we love
San Francisco, United States · Founded 2019 · $180.0M raised
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2C
- Website
- loyal.com
- Total Funding
- $180.0M
- Last Round
- $100.0M Series C
- Rounds
- 4
About
Loyal is a clinical-stage veterinary medicine company developing drugs to extend the healthspan and lifespan of dogs. Its pipeline includes LOY-001, LOY-002, and LOY-003 targeting metabolic dysfunction and IGF-1 overexpression in aging and large-breed dogs. The company has enrolled over 1,300 senior dogs in its pivotal clinical study and has cleared key FDA milestones toward conditional approval.
Summary
Loyal is an Animal Health company based in San Francisco, United States, founded in 2019. It has raised $180.0M in total across 4 rounds. Investors include Khosla Ventures, Bain Capital Ventures and age1.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Unknown
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...